Click on image to view larger version.

Figure 3 Mortality and Composite Ischemia in Subgroups

Comparison of mortality (A) and composite ischemia (B) in patients randomly assigned to UFH or enoxaparin plus a GP IIb/IIIa inhibitor versus bivalirudin monotherapy, displayed as risk ratio (RR) (black boxes) with 95% CI (horizontal lines). CI = confidence interval; CrCl = creatinine clearance; p_int = value for the interaction between the variable and the relative treatment effect; TIMI = Thrombolysis In Myocardial Infarction; other abbreviations as in Figure 1.